drugset
Drugs / Levodopa/Carbidopa
last change Oct 2021 re-read 3 minutes ago

Levodopa/Carbidopa

also known as LD/CD
Developed for
Parkinson disease

Trials 0

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Comparator or background therapy1 trial
Phase 3 NCT04380142 Comparator Oct 2020 → Sep 2021 Parkinson disease AbbVie Completed Met primary

Press releases naming this drug 1 release

DateIssuerRelease
2021-10-28 AbbVie AbbVie Announces ABBV-951 (Foslevodopa/Foscarbidopa) Showed Improvement in Controlling Motor Fluctuations Compared to Oral Levodopa/Carbidopa Medication in Pivotal Phase 3 Trial in Patients with Advanced Parkinson's Disease abbvie.com ↗

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Levodopa/Carbidopa ClinicalTrials.gov intervention name — accepted as the source's own label NCT04380142 ↗
Known as LD/CD “Levodopa/Carbidopa (LD/CD)” NCT04380142 ↗